Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Emory University
NRG Oncology
Tempus AI
Federation Francophone de Cancerologie Digestive
Peking University Cancer Hospital & Institute
Stanford University
NSABP Foundation Inc